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The effect of ventricular fibrillation duration in humans on 
defibrillation efficacy as it pertains to the time of interven- 
tion of an automatic implantable defibrillator is unknown. 
If a difference in defibrillation efficacy exists in the early 
period after ventricular fibrillation onset, it may affect 
algorithms used by antiarrhythmic devices for arrhythmia 
detection and therapy. Therefore, a prospective, random- 
ized evaluation was performed of the effect of ventricular 
fibrillation durations of 10 s and 20 s on defibrillation thres- 
holds in 10 survivors of sudden cardiac arrest undergoing 
implantation of an automatic cardioverter defibrillator. The 
initial duration of ventricular fibrillation was chosen ran- 
domly. Subsequently, each patient served as his or her own 
control for the alternate duration of ventricular fibrillation 
to that chosen initially. 
The mean leading edge defibrillation threshold voltage 
The effect in humans of ventricular fibrillation duration on 
defibrillation efficacy in the period shortly after onset of the 
arrhythmia has relevance to the use of automatic defibrilla- 
tors. With the advent of multiprogrammable automatic im- 
plantable antiarrhythmic devices, the physician will need to 
program a large number of parameters to customize the 
sensing and pulsing functions of the device to individual 
patient needs (1). An important consideration in controlling 
device intervention will be the period of time that ventricular 
fibrillation is allowed to persist before the first defibrillation 
pulse is delivered. Several clinical factors might influence 
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was 411 * 114 V when ventricular fibrillation persisted for 
10 s and 419 + 125 V when it persisted for 20 s (p = 0.73). 
The mean defibrillation threshold current was 11.4 f 2.8 A 
when ventricular fibrillation persisted for 10 s and 11.4 + 
3.2 A when it persisted for 20 s (p = 0.97). The delivered 
energy defibrillation threshold was 11.5 -C 5.9 J when 
ventricular fibrillation persisted for 10 s and 12.0 + 6.9 J 
when it persisted for 20 s (p = 0.67). 
These findings show that the defibrillation threshold 
does not change between 10 and 20 s of ventricular fibril- 
lation in out-of-hospital survivors of cardiac arrest at the 
time of surgical implantation of an automatic defibrillator. 
The data may have influence on the programming of 
defibrillator detection algorithms. 
(J Am Co11 Cardiol1989;13:1362-6) 
whether device intervention should be early or somewhat 
delayed. For example, in patients with frequent episodes of 
nonsustained ventricular tachycardia, delayed application of 
a defibrillation pulse might avoid unnecessary and even 
dangerous intervention into an arrhythmia that otherwise 
would have ended spontaneously (2). On the other hand, too 
great a delay in patients whose ventricular tachycardia is 
sustained or deteriorates into ventricular fibrillation might 
affect outcome by increasing defibrillation energy require- 
ments. The purpose of this study, therefore, was to assess 
defibrillation efficacy in out-of-hospital survivors of cardiac 
arrest at two durations of ventricular fibrillation, one rela- 
tively early and one relatively late, that are relevant to an 
automatic implantable defibrillator detection algorithm. 
Methods 
Study patients. Ten out-of-hospital survivors of cardiac 
arrest were studied intraoperatively after giving informed 
consent during implantation or generator replacement of an 
automatic internal cardioverter/defibrillator or during defi- 
brillation patch placement to prospectively determine the 
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effect of ventricular fibrillation duration on the defibrillation 
threshold. Seven patients were studied during initial pulse 
generator insertion and three patients were studied at the 
time of pulse generator replacement. The null hypothesis 
entertained for this study was that ventricular fibrillation 
duration from 10 s to 20 s would have no effect on detibril- 
lation efficacy. 
Defibrillation techniques. For those seven patients stud- 
ied during initial defibrillator patch insertion, an anterior 
right ventricular patch electrode and a posterolateral left 
ventricular patch electrode (both large CPI model L67 patch 
electrodes) were applied to the epicardium. The three pa- 
tients tested during generator replacement had had their lead 
systems previously inserted with use of the same approach 
as described for the other seven patients. Thus, all 10 
patients had the same electrode configuration used during 
defibrillation threshold testing. Subsequently the electrodes 
were connected to the external defibrillator and ventricular 
fibrillation was initiated with alternating current. All defibril- 
lation threshold testing was performed during normothermia 
without cardiopulmonary bypass. The first attempt at defi- 
brillation was made at either 10 or 20 s after the onset of 
ventricular fibrillation; the initial duration of ventricular 
fibrillation was chosen randomly. During subsequent induc- 
tions of ventricular fibrillation, each patient served as his or 
her own control with ventricular fibrillation persisting alter- 
nately for IO and for 20 s. 
Defibrillation thresholds, irrespective oJ’~~entri~lrlarphril- 
lation duration. were determined by beginning defibrillation 
with a pulse generator energy setting of IO J. The external 
pulse generator used for defibrillation testing delivered a 
single, 65% tilt, truncated exponential waveform pulse. If 
the initial pulse was unsuccessful, a rescue pulse (IO to 20 J 
above the initial pulse energy level) was quickly delivered 
through the same external pulse generator to restore sinus 
rhythm. After a minimal period of recovery of 3 min, 
ventricular fibrillation was reinduced and the alternate dura- 
tion of fibrillation was observed. The same IO J energy pulse 
was then delivered as had been done with the initial duration 
of ventricular fibrillation. Adjustments in pulse amplitude 
were then made for all subsequent attempts at defibrillation 
in 5 J increments or decrements (between energy settings of 
5 and 40 J) and in 2 J increments or decrements (between 
energy settings of 1 and 5 J) until the defibrillation threshold 
was determined. 
Data analysis. During defibrillation pulsing. the voltage 
and current waveforms were monitored with use of two 
Tektronix 2230 digitizing oscilloscopes, which in combina- 
tion with an IBM-AT computer enabled on-line storage and 
analysis of waveforms to determine delivered energy and 
tissue resistance. Statistical analysis of the data was per- 
formed with use of paired t tests to compare the results from 
the two durations of ventricular fibrillation with respect to 
leading edge voltage, leading edge current, resistance, deliv- 
ered energy and stored energy. The defibrillation threshold 
was defined as the lowest energy that could successfully 
terminate ventricular fibrillation with only one discharge 
delivered at 10 or 20 s after initiation of fibrillation. After 
defibrillation thresholds were determined with the initial 
duration of ventricular fibrillation, the defibrillation thresh- 
old was determined with the alternate duration so that each 
patient served as his or her own control. The definition of 
defibrillation threshold chosen for this study is in recognition 
of the fact that defibrillation is, to a degree. a statistical 
phenomenon. Although a dose-response curve is probably 
more scientifically correct, it is impractical and possibly 
dangerous to perform in patients. Our definition of defibril- 
lation efficacy, therefore, adjusts to the necessary clinical 
realities of repetitive induction of ventricular fibrillation in 
the operating room in patients with serious heart disease. 
Results 
Clinical characteristics (Table 1). Of the IO patients stud- 
ied, nine were male and one was female. The mean age was 
62 rt 12 years. Nine patients had coronary artery disease, 
four of whom also had dilated cardiomyopathy. One patient 
had hypertrophic cardiomyopathy. The mean ejection frac- 
tion was 0.35 2 0.1 I. Three patients had been receiving 
maintenance amiodarone therapy at the time of defibrillation 
testing. 
Ventricular fibrillation threshold. The number of ventric- 
ular fibrillation inductions required to determine the defibril- 
lation threshold was similar for both durations of fibrillation 
studied: 2.6 + 0.5 for IO s and 2.5 ? 0.7 for 20 s (p = 0.59). 
There were no complications related to the study. The mean 
leading edge defibrillation threshold voltage was 41 I + 1 I4 V 
when ventricular fibrillation persisted for 10 s and 419 t I25 
V when it persisted for 20 s (p = 0.731). The mean leading 
edge defibrillation threshold current was 1 I .4 t- 2.8 A when 
ventricular fibrillation persisted for 10 s and 1 I.4 t 3.2 A 
when it persisted for 20 s (p = 0.974). The resistance at the 
defibrillation threshold was 36.2 c 5.7 R for pulses delivered 
after IO seconds of ventricular fibrillation and 37.0 I 6.4 0 
for pulses delivered after 20 s of ventricular fibrillation (p = 
0.268). The delivered energy defibrillation threshold was 
1 I .5 .t 5.9 J when ventricular fibrillation persisted for IO s 
and 12.0 -e 6.9 J when it persisted for 20 s (p = 0.670) (Fig. 
I). The stored energy defibrillation threshold was 13.7 + 6.8 
J when ventricular fibrillation persisted for IO s and 14.4 +- 
8.0 J when it persisted for 20 s (p = 0.643). 
Of the IO patients, 5 (50%) had no difference in delivered 
energy defibrillation threshold (> I J) regardless of ventricu- 
lar fibrillation duration, 2 (20%) had a lower defibrillation 
threshold when ventricular fibrillation persisted for IO s, and 
3 (30%) had a lower defibrillation threshold when fibrillation 
persisted for 20 s. 
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Table 1. Clinial Characteristics of 10 Patients 
Patient Age tyr) Clinical 
No. & Gender Arrhythmia 
Cardiac 
Diagnosis LVEF Drugs 
Surgical 
Procedure 
1 69M 
2 40M 
3 54M 
4 66F 
5 64M 
6 64M 
7 73M 
8 44M 
9 74M 
IO 70M 
Mean 62 
+ SD 212 
VF 
VF 
VT 
VT to VF 
VF 
VF 
VF 
VT 
VF 
VF 
CAD, DMI. AMI 
HCM 
IDC. CAD, LMI 
IDC, CAD. SIP. CABG 
CAD, DMI, HHD 
CAD, S/P CABG 
CAD 
IDC, CAD. AMI, S/P ER 
CAD, AMI 
CAD. AMI 
0.27 
0.57 
0.38 
0.33 
0.49 
0.22 
0.30 
0.23 
0.35 
0.40 
0.35 
i-O.11 
- AICD t CABG 
Amio AICD replacement 
- ER, AICD 
- AICD replacement 
- CABG x 3, electrode patches only 
Amio AICD 
Amio AICD 
- AICD replacement 
- AICD t CABG 
- AICD t CABG 
AICD = automatic internal cardioverterldefibrillator: AMI = anterior myocardial infarction; Amio = amiodarone: CABG = coronary artery bypass grafting; 
CAD = coronary artery disease; DMI = diaphragmatic myocardial infarction; ER = endocardial resection: F = female: HCM = hypertrophic cardiomyopathy; 
HHD = hypertensive heart disease; IDC = idiopathic dilated cardiomyopathy; LMI = lateral myocardial infarction: LVEF = left ventricular ejection fraction; 
M = male; MR = mitral regurgitation: S/P = status post: VF = ventricular fibrillation: VT = ventricular tachycardia. 
Discussion 
Implications for detection algorithms. Our study demon- 
strates that defibrillation efficacy obtained with epicardial 
patch electrodes in humans does not vary significantly for 
ventricular fibrillation duration between 10 and 20 s in 
out-of-hospital cardiac arrest survivors. This finding may 
have significance in determining how a multiprogrammable 
automatic antiarrhythmic device should be programmed. 
For instance, in patients with both frequent nonsustained 
ventricular tachycardia and sustained ventricular tachycar- 
dia or ventricular fibrillation, the managing electrophysiolog- 
ist might prefer to program a longer detection time before the 
device declares detection of ventricular tachycardia or ven- 
tricular fibrillation. 
In patients with nonsustained ventricular tachycardia, 
programming of a longer time period before arrhythmia 
detection is declared might avoid delivery of shocks during 
sinus rhythm after an episode of nonsustained ventricular 
Figure 1. Defibrillation threshold delivered energy (DFT) after ven- 
tricular fibrillation duration of 10 s and 20 s in IO out of hospital 
survivors of ventricular fibrillation undergoing automatic defibril- 
lator implantation. 
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tachycardia (2,3). However, commanding a wait of 20 s 
rather than 10 s before device intervention would be prudent 
only if rescuing the patient at 20 s into an episode of 
ventricular fibrillation did not require significantly more 
energy than would be required for rescue at the earlier time 
of 10 s. If requirements for defibrillation were significantly 
higher at 20 s than at 10 s, intervention earlier in an episode 
would be preferable, even at the risk of patient discomfort or 
proarrhythmia as a result of shocking during sinus rhythm. 
The duration of ventriculur jibrillation is relevant in 
another situation. When device intervention is requested at 
10 s rather than at 20 s, considerable demands are placed on 
the rapidity and accuracy of ventricular fibrillation detec- 
tion. If 20 s rather than 10 s of ventricular fibrillation is 
required, the device may be more accurate in its response. 
Because problems in detection sensitivity and specificity of 
ventricular fibrillation already exist, it would be wise to 
avoid algorithms that would press a device to intervene more 
quickly than the currently possible time period, typically I5 
to 25 s (4). 
Other factors may influence whether one might intervene 
early or late with II shock. In patients who have an initially 
organized and regular arrhythmia (for example, monomor- 
phic ventricular tachycardia), some pacing intervention 
might be preferable to a shock, but only if the patient is not 
ultimately at risk of developing an arrhythmia that is more 
difficult to terminate. For example, if successive attempts to 
pace-terminate ventricular tachycardia fail, the patient could 
become hypoxic and acidotic and the rhythm might degen- 
erate into ventricular fibrillation. In this setting, it might 
become more difficult to terminate ventricular fibrillation if 
duration of arrhythmia were a prominent factor. Therefore, 
it may be judicious to place some reasonable time limit on 
pacing interventions. Our study provides some pertinent 
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Table 2. Electrical Parameters for Defibrillation Thresholds as a Function of Fibrillation Duration 
Number of 
VF Inductions 
Patient ____ 
No. IO 5 20 \ 
Voltage Current Ke\lctancz Delivered Energ) Stored Energy 
(VJ (A) lOI IJ) IJ) 
IO \I 20 5 IO \ 20 , IO \ ‘0 ‘I IO \ 20 \ IO s 20 s 
2 
4 
5 
6 
7 
x 
Y 
IO 
Mean 
t SD 
P 
4 
3” 2 4Yi JY? 11.x II.1 .11.7 13.’ 15.4 15.4 18.0 18.0 
2 7. 551 640 IS 0 17.0 t7. I X7.6 20. I 25.9 21.4 30.8 
,* 1 496 304 10.x X.X -43.X -15.7 14.5 Y7 IX.1 12.1 
1 1x 404 305 I! I 13.0 10.9 II.2 IO.5 IO T 12.6 12.6 
3’ 3 302 293 IO.5 6.X IX.1 43.0 IO.6 5.3 12.1 6.4 
3 3‘ 291 407 6.9 9.6 41.1 17.3 5.2 10.6 6.3 11.3 
2 2^ 407 490 12.X 14.1 31.9 -34.5 IO.3 14.7 12.7 18.2 
3 2, 568 F64 IS 6 15.1 36.4 .37. I 20.6 20.3 71.4 24.0 
3* 4 279 1X1 10.6 10.6 16.3 26.3 4.X 4.Y 6.1 6.2 
i* 3 !I7 717 6X 7.6 (1 x 7X.6 2.X 1.x 3.6 3.7 
1.6 2,s 411 419 II.4 I I.4 36.2 77.0 II.5 12.0 13.7 14.4 
IO.5 i0.7 1114 ?I?5 k2.X t3.2 - _) 76.4 15.9 ?6.Y Z6.X -cx.o 
-0.iY = 0.71 =O.Y7 =0.27 =O.h? =0.64 
“Duration of ventricular fibrillation that WY evaluated first Note that stnred energy calws do not \impl) reflect the product of I” CV’. Differenccj between 
capacitor voltage and delivered vokige need to be conGdered (171. VF r ventricular fibrillation. 
information in relation to this scenario by implying that 
antitachycardia pacing maneuvers are probably safe for ~30 
s without risk of raising defibrillation requirements. 
Fibrillation duration and the present defibrillator. Our 
study also has some relevance to the currently available 
nonprogrammable automatic implantable cardioverter defi- 
brillator (CPI Ventak). Although this device is nonprogram- 
mable, the managing physician can influence the timing of its 
intervention in an episode of ventricular fibrillation by 
selecting the trigger rate and by choosing a detection algo- 
rithm that utilizes rate only or that utilizes the probability 
density function in addition to rate. For example, it might be 
possible to prolong the time the present device takes to sense 
ventricular fibrillation by choosing a high rate device with a 
probability density function. On the other hand, units that 
sense only rate and also have low rate detection cut-offs 
might be selected in an attempt to shorten ventricular 
fibrillation detection time. 
Finally, our jindings how some implicatiot~s for dinictrl 
defibrillation threshold tcJstin,q. We (5-7) as well as others (X- 
IO) routinely test defibrillation effectiveness at 5 IO s intra- 
operatively (Table 2). Few of the present automatic defibril- 
lators. however, discharge before such a short time period. 
Usually, there is an interval of 15 to 25 s between the onset 
of ventricular fibrillation and delivery of the shock when the 
present automatic defibrillator is used (4). This interval is 
dependent on many factors including the mean ventricular 
fibrillation cycle length, variability in ventricular fibrillation 
electrogram amplitude, detection rate of the device, pres- 
ence or absence of a probability density function detector 
and capacitor charge time. Determination of defibrillation 
efficacy during defibrillation threshold testing ideally should 
approximate the clinical function of the device as closely as 
possible with respect to the time of intervention into an 
episode of ventricular fibrillation. However. repetitive intra- 
operative inductions of ventricular fibrillation with the asso- 
ciated hypotension may be less easy to accomplish at 
fibrillation durations of 20 s than at durations of 10 s; 
therefore. it is useful to know from our data that testing 
defibrillation efficacy at IO s is a clinically reasonable time 
period. 
Previous studies on fibrillation duration and defibrillation 
efficacy. It is pertinent to discuss our findings in relation to 
other animal and human studies evaluating the effect of 
ventricular fibrillation duration on defibrillation outcome. In 
two previous clinical studies (11.12) evaluating out- 
of-hospital trrrnsthoracic defibrillation. the effect of ventric- 
ular fibrillation duration on defibrillation effectiveness was 
generally inconsequential, except after prolonged periods. In 
a study by Gascho et al. (I 1) attempts to perform transtho- 
racic defibrillation at various intervals between 0 and 120 s 
after cardiac arrest were of comparable efficacy. Similarly, 
Kerber and Sarnat (12) showed that defibrillation attempts 
between I and 10 min after the onset of cardiac arrest 
generally had similar success rates. Only when ventricular 
fibrillation persisted for >I0 min did transthoracic defibril- 
lation efficacy decrease. In a canine defibrillation study by 
Tacker et al. (13). evaluating defibrillation efficacy with an 
intracardiac catheter shortly after the onset of ventricular 
fibrillation, no difference in defibrillation threshold was 
found between fibrillation durations of IO and 40 s. Black et 
al. (14). in a catheter-patch canine study, had similar findings 
showing no significant difference in defibrillation efficacy 
between IS and 30 s of ventricular fibrillation. In addition, 
Babbs et al. (15) showed that the defibrillation threshold may 
actually decrease after 2 min of ventricular fibrillation be- 
cause of favorable changes in extracellular potassium con- 
centration. These studies are consistent with ours. 
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In other studies, however, ventricularjibrillation duration 
has made a diference. In the dog study by Black et al. (14) 
and in a clinical study by Winkle et al. (16), defibrillation 
performed very early, at 5 s after ventricular fibrillation 
onset, was more effective than that performed at later time 
periods. This improved efficacy at 5 s compared with later 
times may be related to the finding that ventricular fibrilla- 
tion is relatively slower and more organized in the first few 
seconds and, therefore, sinus rhythm is easier to restore in 
this first 5 s period (14). However, such early intervention 
places considerable demands on the accuracy of detection 
algorithms and increases the likelihood of shocking into 
nonsustained arrhythmias, arrhythmias that perhaps are best 
left alone. Although ventricular fibrillation may well be more 
easily defibrillated at a duration of 5 s than at longer 
durations, practical concerns over arrhythmia detection and 
therapy make this duration of ventricular fibrillation less 
suitable for therapeutic decision-making by an automatic 
antiarrhythmia device. In the more relevant time period for 
device intervention of 10 to 20 s after the onset of ventricular 
fibrillation, the significance of defibrillation efficacy with 
respect to fibrillation duration appears to be minor. 
References 
I. Yee R, Guiraudon G. Jones DL. et al. Implantation of a pacemaker/ 
cardioverteridefibrillator in men: initial results of a new generation device 
(abstr). J Am Coil Cardiol 1988;11:208A. 
2. Maloney JD, Wilkoff B, Simmons T, Morant V, Golding LAR, Castle L. 
Clinical performance of automatic implantable cardioverter defibrillator: 
electrocardiographic documentation of82 spontaneous discharges (abstrl. 
J Am Co11 Cardiol 1988;ll:18A2. 
3. Poole JE, Troutman CL, Anderson J, Bardy GH, Greene HL. lnappro- 
priate and appropriate discharges of the automatic implantable cardio- 
verter defibrillator (abstr). J Am Coll Cardiol 1988;11:21OA\. 
4. Winkle RA, Bach SM, Echt DS, et al. The automatic implantable 
defibrillator: local ventricular bipolar sensing to detect ventricular tachy- 
cardia and fibrillation. Am J Cardiol 1983:52:265-70. 
5. Bardy GH, lvey TD. Stewart RB. Graham EL, Greene HL. Failure of the 
automatic implantable defibrillator to detect ventricular fibrillation. Am J 
Cardiol 1986;58: 1107-8. 
6. Bardy GH, lvey TD. Johnson G, Stewart RB, Greene HL. A prospective 
evaluation of initially ineffective defibrillation pulses on subsequent 
defibrillation success during ventricular fibrillation in survivors of cardiac 
arrest. Am J Cardiol 1988:62:718-22. 
7. Bardy GH. Stewart RB, lvey TD, Graham EL. Adhar GC, Greene HL. 
Intraoperative comparison of sequential pulse and single pulse defibrilla- 
tion in candidates for automatic implantable defibrillators. Am J Cardiol 
1987:60:618-24. 
8. Marchlinski SE. Flores BT. Buxton AE, et al. The automatic implantable 
cardioverter-defibrillator: efficacy, complications, and device failures, 
Ann Intern Med 1986;104:481-8. 
9. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. 
Clinical experience, complications, and survival in 70 patients with the 
automatic cardioverteridefibrillator. Circulation 1985;71:289-96. 
IO. Troup PJ. Chapman PD, Olinger GN, Kleinman LH. The implanted 
defibrillator: relation of defibrillating lead configuration and clinical vari- 
ables to defibrillation threshold. J Am Coll Cardiol 1985;6: 1315-21. 
1 I. Gascho JA, Crampton RS, Cherwek ML, Sipes JN, Hunter FB, O’Brien 
WM. Determinants of ventricular defibrillation in adults. Circulation 
1979:60:231-40. 
12. Kerber RE, Sarnat W. Factors influencing the success of ventricular 
fibrillation in man. Circulation 1979;60:226-30. 
13. Tacker WA. Babbs CF, Parris RL, Bourland JD. Effect of fibrillation 
duration on defibrillation threshold in dogs using a pervenous catheter- 
electrode designed for use with an automatic implantable defibrillator 
(abstr). Medical lnstrum 1981:15:327-8. 
14. Black JN, Barbey JT, Echt DS. Ventricular fibrillation duration affects 
defibrillation (abstr). J Am Co11 Cardiol 1987;9: 142A. 
15. Babbs CF. Whistler SJ, Yim GKW, Tacker WA, Geddes LA. Depen- 
dence of defibrillation threshold upon extracellular/intracellular Kt con- 
centrations. J Electrocardiol 1980;13:73-8. 
16. Winkle RA, Mead RH, Ruder MA, et al. Defibrillation efficacy in man 
after 5 vs 15 seconds of ventricular fibrillation (abstr). J Am Coll Cardiol 
1988:l l:l8A. 
17. Bardy GH, lvey TD, Allen MD, Johnson G, Greene HL. Prospective 
comparison of sequential pulse and single pulse defibrillation using two 
different clinically available systems. J Am Co11 Cardiol (in press). 
